{"title":"High risk of death following a hip fracture in patients with COPD","authors":"","doi":"10.1016/j.rmedu.2008.02.007","DOIUrl":null,"url":null,"abstract":"<div><p>Introduction: Mortality rates after hip fracture have not declined in 20 years. We assessed the impact of chronic obstructive pulmonary disease (COPD) on mortality after hip fracture, and compared mortality in this cohort to persons without hip fracture in a population-based prospective cohort study.</p><p>Methods: Using Danish health care registries, we identified persons >/=40 years old with first-time hospitalization for hip fracture between 1/1/1998 and 1/31/2003. Hospitalization for COPD was assessed from hospital discharge registries. Using Cox regression, we computed relative risks (RR) and 95% confidence intervals (CI) for mortality endpoints among persons with COPD compared to persons without COPD. Mortality following hip fracture was also compared to age and gender matched controls without hip fracture.</p><p>Results: We identified 11,985 persons with first-time hospitalization for hip fracture; 771 (6.4%) had a diagnosis of COPD. Average follow up was 22 months. Compared to persons without COPD, mortality following hip fracture in persons with COPD was RR=1.58 (95% CI 1.30–1.90) at 30 days, RR=1.52 (95% CI 1.30–1.77) at 90-days, RR=1.58 (95% CI 1.40–1.78) at 1 year, and RR=1.71 (95% CI 1.55–1.88) overall. The 1-year mortality in persons with hip fracture and COPD was approximately 3–5 times greater than in controls without hip fracture.</p><p>Conclusions: In this cohort, persons with COPD have a 60–70% higher risk of death following hip fracture than those without COPD. In addition, hip fracture and COPD increased 1-year mortality 3–5 times that of persons without hip fracture.</p><p>Reproduced with permission from Springer</p></div>","PeriodicalId":101083,"journal":{"name":"Respiratory Medicine: COPD Update","volume":"4 2","pages":"Page 77"},"PeriodicalIF":0.0000,"publicationDate":"2008-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rmedu.2008.02.007","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Medicine: COPD Update","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1745045408000154","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Mortality rates after hip fracture have not declined in 20 years. We assessed the impact of chronic obstructive pulmonary disease (COPD) on mortality after hip fracture, and compared mortality in this cohort to persons without hip fracture in a population-based prospective cohort study.
Methods: Using Danish health care registries, we identified persons >/=40 years old with first-time hospitalization for hip fracture between 1/1/1998 and 1/31/2003. Hospitalization for COPD was assessed from hospital discharge registries. Using Cox regression, we computed relative risks (RR) and 95% confidence intervals (CI) for mortality endpoints among persons with COPD compared to persons without COPD. Mortality following hip fracture was also compared to age and gender matched controls without hip fracture.
Results: We identified 11,985 persons with first-time hospitalization for hip fracture; 771 (6.4%) had a diagnosis of COPD. Average follow up was 22 months. Compared to persons without COPD, mortality following hip fracture in persons with COPD was RR=1.58 (95% CI 1.30–1.90) at 30 days, RR=1.52 (95% CI 1.30–1.77) at 90-days, RR=1.58 (95% CI 1.40–1.78) at 1 year, and RR=1.71 (95% CI 1.55–1.88) overall. The 1-year mortality in persons with hip fracture and COPD was approximately 3–5 times greater than in controls without hip fracture.
Conclusions: In this cohort, persons with COPD have a 60–70% higher risk of death following hip fracture than those without COPD. In addition, hip fracture and COPD increased 1-year mortality 3–5 times that of persons without hip fracture.
导言:髋部骨折后的死亡率20年来没有下降。我们评估了慢性阻塞性肺疾病(COPD)对髋部骨折后死亡率的影响,并在一项基于人群的前瞻性队列研究中比较了该队列与非髋部骨折患者的死亡率。方法:使用丹麦卫生保健登记,我们确定了1998年1月1日至2003年1月31日期间因髋部骨折首次住院的40岁患者。根据出院登记对COPD住院进行评估。使用Cox回归,我们计算了COPD患者与非COPD患者死亡率终点的相对危险度(RR)和95%置信区间(CI)。髋部骨折后的死亡率也与没有髋部骨折的年龄和性别匹配的对照组进行了比较。结果:我们确定了11985例首次因髋部骨折住院的患者;771例(6.4%)被诊断为COPD。平均随访时间为22个月。与非COPD患者相比,COPD患者髋部骨折后30天的死亡率RR=1.58 (95% CI 1.30-1.90), 90天的RR=1.52 (95% CI 1.30-1.77), 1年的RR=1.58 (95% CI 1.40-1.78),总体RR=1.71 (95% CI 1.55-1.88)。髋部骨折合并COPD患者的1年死亡率约为无髋部骨折对照组的3-5倍。结论:在该队列中,COPD患者髋部骨折后死亡风险比非COPD患者高60-70%。此外,髋部骨折和慢性阻塞性肺病患者1年死亡率是无髋部骨折患者的3-5倍。经Springer许可转载